Gene that causes tamoxifen resistance in breast cancer

Release date: 2014-07-28

Recently, researchers have discovered that new genetic markers may help predict whether estrogen receptor (ER)-positive breast cancer patients are likely to benefit from tamoxifen treatment. The study was published in Cancer Research on July 15. In the magazine.

The Dutch Cancer Institute Hendrika M. Oosterkamp and his colleagues performed large-scale functional deletion gene screening in ZR-75-1 luminal breast cancer cells to identify candidate genes that cause tamoxifen resistance. The researchers found that the loss of ubiquitinating enzyme USP9X function can offset the efficacy of tamoxifen in preventing cancer proliferation.

In the presence of tamoxifen, the differentially expressed gene USP9X can be used to determine that patients with ERα-positive breast cancer experience a poor prognosis after undergoing tamoxifen-assisted therapy. However, in breast cancer patients who did not receive endocrine therapy, no correlation was found between gene signature and patient survival.

Overall, the findings determined that the gene signature USP9X could be used as a candidate biomarker for breast cancer patients in response to tamoxifen treatment.

Source: Bio Valley

Spike Port

Our spike ports are widely applied in transfusion soft bag packing issues. Our products have perfect sealing capacity and can fit in with soft pipe well. We have advanced product design and process craft.The patent design helps prevent falling rubber chip gasket,this ensures the product very low needle chip drop and good puncture retention,it can also reduce hospital complaints.Our ports are easy to open, can completely eliminate the impact of aluminum chips and give excellent safety performance.We now have ten thousand production workshop, local production under 100 class conditions, to ensure the cleanliness of the products. A special structure is adopted to ensure that the completely closed cover body can be opened quickly, and the safety and cleanliness of clinical use are guaranteed, and the patent certificate has been obtained.

Spike Port,Disposable Infusion Spike Port,Medical Infusion Spike Port,Infusion Spike Port

SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , https://www.crh-health.com